ERYTECH Provides Business Update and Reports Financial Highlights for Third Quarter 2016 admERY November 3, 2016 Newsroom ERYTECH today provided a business update and reported its financial results for the quarter ended September 30, 2016. You Might Also Like ERYTECH to Present Two Posters at AACR March 17, 2016 ERYTECH Completes Patient Enrollment in Phase 2b Trial for eryaspase (GRASPA®) in Acute Myeloid Leukemia August 29, 2016 ERYTECH wins EuropaBio’s Most Innovative European Biotech SME Award 2014 October 9, 2014
ERYTECH Completes Patient Enrollment in Phase 2b Trial for eryaspase (GRASPA®) in Acute Myeloid Leukemia August 29, 2016
